Response Oncology, Inc.
Response Oncology, Inc.
Share · US7612323052 (OTC)
Overview
No Price
n/a
Company Profile for Response Oncology, Inc. Share
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Get up to date insights from finAgent about Response Oncology, Inc.

Company Data

Name Response Oncology, Inc.
Company Response Oncology, Inc.
Primary Exchange OTC UTC
ISIN US7612323052
Asset Class Share
Sector Healthcare
Industry Medical - Care Facilities
CEO Charles E. Sweet
Country United States of America
Currency USD
Employees 0,0 T
IPO Date 2000-01-03

Ticker Symbols

Name Symbol
Over The Counter ROIX
More Shares
Investors who hold Response Oncology, Inc. also have the following shares in their portfolio:
JOHN DEERE C 21/31 MTN
JOHN DEERE C 21/31 MTN Bond
NORDLB GELDM.FRN 08/18
NORDLB GELDM.FRN 08/18 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025